TD Cowen Upgrades MacroGenics (MGNX) to Buy, 'We Believe There Is Favorable Risk/Reward Heading Into The Efficacy Update By The End Of May'
Tweet Send to a Friend
TD Cowen analyst Boris Peaker upgraded MacroGenics (NASDAQ: MGNX) from Hold to Buy.The analyst comments "Initial Phase II safety beat ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
